Dawnrays Pharmaceutical (Holdings) Limited

Announcements & Notices       

2019-December-30	POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 DECEMBER 2019 (in PDF)
2019-December-24	DISCLOSEABLE TRANSACTION MARKETING AUTHORIZATION HOLDER (MAH) IN RESPECT OF FEBUXOSTAT (in PDF)
2019-November-20	NOTICE OF EXTRAORDINARY GENERAL MEETING (in PDF)
2019-August-28	GRANT OF OPTIONS (in PDF)
2019-August-27	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019 (in PDF)
2019-August-13	DATE OF BOARD MEETING (in PDF)
2019-August-1	CLARIFICATION ANNOUNCEMENT RELATING TO GRANT OF SHARE OPTIONS (in PDF)
2019-July-15	UPDATED INFORMATION OF THE GROUP'S PRODUCTS (in PDF)
2019-June-18	GRANT OF SHARE OPTIONS (in PDF)
2019-June-17	CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE (in PDF)
2019-May-29	Terms of Reference for Audit Committee (in PDF)
2019-May-29	Terms of Reference for Nomination Committee (in PDF)
2019-May-29	Terms of Reference for Remuneration Committee (in PDF)
2019-May-24	POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2019 (in PDF)
2019-May-7	DISCLOSEABLE TRANSACTION-COMPLETION OF THE ACQUISITION OF TOP FIELD LIMITED (in PDF)
2019-April-30	UPDATE TO DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF TOP FIELD LIMITED (in PDF)
2019-April-15	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2019-March-21	ANNOUNCEMENT OF THE ANNUAL RESUTLS FOR THE YEAR ENDED 31 DECEMBER 2018 (in PDF)
2019-March-8	DATE OF BOARD MEETING (in PDF)
2019-February-27	Discloseable Transaction in Relation to Framework Agreement for the Acquisition of Top Field Limited (in PDF)
2019-January-9	GRANT OF SHARE OPTIONS (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices